Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of COVID19 Infection by the Administration of Hydroxychloroquine to Institutionalized Older People and Nursing Home Staff. Controlled Clinical Trial, Randomized Triple Blind by Clusters (PREVICHARM Study)

NCT04400019 is registered in ClinicalTrials.gov with University of Malaga as lead sponsor.

NCT NCT04400019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04400019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of COVID19 Infection by the Administration of Hydroxychloroquine to Institutionalized Older People and Nursing Home Staff. Controlled Clinical Trial, Randomized Triple Blind by Clusters (PREVICHARM Study)
Lead sponsor
University of Malaga
Phase
Phase 2/3
Overall status
Unknown status
Start date
September 30, 2020
Completion date
April 1, 2021
Enrollment
1,930 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, hydroxychloroquine, nursing home, prevention & control, sars-cov2